scorecardresearch
Friday, April 19, 2024
Support Our Journalism
HomeWorldUK to confirm Covid vaccine milestone for care home residents amid concerns...

UK to confirm Covid vaccine milestone for care home residents amid concerns over supplies

The UK aims to offer vaccines to 15 million people in its top four priority groups by 15 Feb, which includes care home residents, people over 70, and frontline workers.

Follow Us :
Text Size:

London: The U.K. is set to confirm that residents at every eligible care home in England have been offered a Covid-19 vaccine, even as a dispute over exports from Europe raises concern over supplies.

Jabs have been offered to eligible residents of more than 10,000 homes where possible, official figures are set to show later Monday. The announcement comes after reassurances yesterday by International Trade Secretary Liz Truss that the nation’s supply of vaccines is secure and the country will stick to its rollout timetable.

The U.K. aims to offer vaccines to about 15 million people in its top four priority groups by Feb. 15. That includes care home residents, people over 70, frontline health care workers and the clinically extremely vulnerable. So far, a total of 8,977,32 people have received their first dose, with a record number of almost 600,000 people being jabbed on Saturday alone, government data show.

Prime Minister Boris Johnson described the care home figures as “a crucial milestone in our ongoing race to vaccinate the most vulnerable.” Even so, he warned that the number of cases and people in the hospital remains dangerously high. Over 100,000 people have died in the U.K. after testing positive for the virus.

Among those hospitalized with Covid is Captain Tom Moore, the 100-year-old veteran who has raised almost 40 million pounds ($55 million) for the nation’s health service.

The government is “absolutely confident” it can continue to deliver its vaccine plan, Truss told Sky News on Sunday. Her comments came after the European Union’s executive arm announced it would require manufacturers to obtain authorization before sending shots manufactured in the bloc to some other countries. That raised concerns over the provision of supplies of the Pfizer Inc. and BioNTech SE shot, manufactured in Belgium, to the U.K.

The origin of the dispute is AstraZeneca Plc’s decision to prioritize Britain over the EU following a Belgian production glitch, in what Brussels claims was a breach of contract. After a flurry of activity, AstraZeneca agreed to deliver 9 million additional vaccine doses to the EU in the first quarter of this year, bringing the total to 40 million for the period, European Commission President Ursula von der Leyen said Sunday on Twitter.

The spat caused uproar after a threat by the EU to unilaterally trigger emergency clauses in its post-Brexit accord with the U.K., which officials have since backtracked on. Irish Taoiseach Micheal Martin told the BBC that people had been “blindsided” by the move, while former Prime Minister Tony Blair described it as “very foolish” and said it risked endangering Ireland’s 1998 Good Friday Agreement peace deal.

Von der Leyen on Sunday held a video call with chief executives of pharmaceutical companies to discuss how vaccines could be more rapidly deployed, manufactured and approved in the future.

“The pandemic highlighted that manufacturing capacities are a limiting factor. It is essential to address these challenges,” the commission said in a statement after the call. It added that “the emergence of variants of concern raises the imminent threat of reduced efficacy of recently approved vaccines.” – Bloomberg


Also read: 1 year and 1 lakh Covid deaths later, UK faces up to painful pandemic lessons


 

Subscribe to our channels on YouTube, Telegram & WhatsApp

Support Our Journalism

India needs fair, non-hyphenated and questioning journalism, packed with on-ground reporting. ThePrint – with exceptional reporters, columnists and editors – is doing just that.

Sustaining this needs support from wonderful readers like you.

Whether you live in India or overseas, you can take a paid subscription by clicking here.

Support Our Journalism

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular